Skip to main content
Clinical Trials/IRCT20150715023218N1
IRCT20150715023218N1
Recruiting
Phase 1

Investigation on Safety and Efficacy of Autologous Human Fibroblasts Transplantation in Regeneration of Atrophic Cutaneous Leishmaniasis Scar.

Iran University of Medical Sciences0 sites5 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
5
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Ages 15\-65
  • Scar lesions caused by Cutaneous leishmaniasis grade 3 to 7;
  • The willingness to provide informed consent for participation in the trial and the ability to communicate with the investigator during follow ups.

Exclusion Criteria

  • Use of Retinoids in the last 6 months
  • Laser therapy in the last 6 months
  • Cancer or any chronic systemic disease
  • Chemical therapy
  • Mesotherapy
  • Active infection to Leishmaniasis in the scar
  • Oragan or cell transplantation
  • Autoimmune disease
  • Breast feeding
  • Dermal Filler in the last 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials